Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

B012632

Team news, Careers 07/08/2023

Jay Ruaux in profile

Seeking Clarity

European, News 07/08/2023

Seeking Clarity: The Controversy Surrounding Article 84 EPC and Description Adaption

Farm to Fork Patents IP

European, News 02/08/2023

Farm to fork: Innovating to create a sustainable food system

EPO

European, News 01/08/2023

Abolition of the European Patent Office’s ten-day rule draws closer

Secerna Header Images (5)

Events, News 21/07/2023

Join us at the Medical Technology Ireland Expo & Conference

Shep Mcallister J1j3cimjmge Unsplash

Industry news, News 17/07/2023

The Centre Court role of intellectual property at Wimbledon

European Patent Office Building

News 14/07/2023

New Referral to Enlarged Board of Appeal at the EPO regarding level of disclosure of prior art complex products

Taster Day July 2023

Events, News 12/07/2023

Secerna's Taster Day Unveils the Excitement of a Career in Patent Law

JP3 2544

Industry news, News 05/07/2023

Secerna LLP Receives Ongoing Recognition as a Leading Firm by IAM 1000

14 15 16 17 18 19 20 21 22 23 24